National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 39,863 cases where Vaccine is COVID19 and Symptom is Anaphylactic reaction or Anaphylactic shock or Anaphylactoid reaction or Anaphylactoid shock or Swollen tongue or Tongue paralysis or Tongue pruritus or Urticaria or Urticaria aquagenic or Urticaria cholinergic or Urticaria chronic or Urticaria contact or Urticaria generalised or Urticarial vasculitis or Urticaria papular or Urticaria pigmentosa or Urticaria pressure or Urticaria thermal or Urticaria vesiculosa

Government Disclaimer on use of this data



Case Details

This is page 21 out of 3,987

Result pages: prev   12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30   next


VAERS ID: 907545 (history)  
Form: Version 1.0  
Age: 32.0  
Sex: Female  
Location: Unknown  
Vaccinated:2020-12-21
Onset:2020-12-21
   Days after vaccination:0
Submitted: 2020-12-22
   Days after onset:1
Entered: 2020-12-23
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK5730 / 2 LA / -

Administered by: Other       Purchased by: Other
Symptoms: Injection site warmth, Skin warm, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Has allergy with prior reaction to sulfa drugs that she had the same symptoms of warmth and then developed hives. Her left upper extremity was warm to the touch when compared to her right, which was where she received her injection 20 minutes prior. Treated with motrin and benadryl 50mg po and symptoms resolved.


VAERS ID: 907574 (history)  
Form: Version 1.0  
Age: 55.0  
Sex: Male  
Location: Unknown  
Vaccinated:2020-02-18
Onset:2020-12-18
   Days after vaccination:304
Submitted: 2020-12-22
   Days after onset:4
Entered: 2020-12-23
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EH9899 / 2 RA / -

Administered by: Other       Purchased by: Other
Symptoms: Anxiety, Swollen tongue, Throat tightness
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Oropharyngeal allergic conditions (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Approximately one hour after receiving the vaccine, as the patient was driving home he began experiencing throat tightness and tongue swelling. Once home, they call 911 and administered 0.3 epi (had previous severe allergy to lidocaine). EMS then administered iv benadryl and an albuterol treatment. The patient was reported to go unresponsive en route and received bag and mask ventilation very briefly as well as additional 125g solumedrol and another IM epi injection. On arrival he was reported to be stable, talking, tolerating secretions, without significant complaints. He was observed in the ER for several hours without any symptoms nor objective findings to support anaphylaxis (tongue and airway normal, no wheeze, no rash). He was anxious in the ER and the treating physician wrote that he felt it may likely have been anxiety and not anaphylaxis based on their evaluation.


VAERS ID: 907590 (history)  
Form: Version 2.0  
Age: 30.0  
Sex: Female  
Location: Oregon  
Vaccinated:2020-12-21
Onset:2020-12-21
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK5730 / 1 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Flushing, Hyperventilation, Rash, Throat tightness, Urticaria
SMQs:, Anaphylactic reaction (narrow), Angioedema (narrow), Asthma/bronchospasm (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Eosinophilic pneumonia (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Accutain, Premarin, Melixicam, Zyrtec
Current Illness: No other illnesses
Preexisting Conditions: Hysterectomy, prophylactic mastectomy. Ankylotic spondylitis
Allergies: Latex allergy. Penicillin. Ciprofloxacin causes anaphylaxis. Had anaphylaxis in 2010 or 2012 with oral Ciprofloxacin.
Diagnostic Lab Data: Resides in healthcare workers'' patient medical record. She was evaluated by Dr. in the Emergency Department.
CDC Split Type:

Write-up: Minutes after being vaccinated; patient felt flushed and arms and back and chest developed hives/rash. Hyperventilation with throat tightness. Healthcare worker was immediately transported to the Emergency Department and was treated with Benadryl, Epinephrine, Solu-medrol, Pepcid and Ativan.


VAERS ID: 907616 (history)  
Form: Version 2.0  
Age: 53.0  
Sex: Female  
Location: New Mexico  
Vaccinated:2020-12-18
Onset:2020-12-18
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK5730 / 1 - / IM

Administered by: Other       Purchased by: ?
Symptoms: Anaphylactic reaction, Dyspnoea, Hypersensitivity, Pruritus, Urticaria
SMQs:, Anaphylactic reaction (narrow), Angioedema (narrow), Anaphylactic/anaphylactoid shock conditions (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Past Medical History: Diagnosis Date ? Addison''s disease (CMS-HCC) 03/2015 ? Asthma (CMS-HCC) ? Disorder of thyroid (CMS-HCC)
Allergies: meperidine, morphine=anaphylaxis flagyl=pancreatitis
Diagnostic Lab Data:
CDC Split Type:

Write-up: 12-22 HPI 53-year-old female with a history of Addison''s disease, anaphylactic reaction who presents to the ED complaining of hives and shortness of breath. Patient reports that 3 days ago she received the COVID-19 pfizer vaccine. She reports that since that time she has developed progressively worsening hives on her legs and arms. Approximately 1 hour ago she began to develop shortness of breath and so she presented to the ER. Patient reports a previous history of anaphylactic reactions multiple times. Denies any other acute complaints at this time. MDM Patient came in with shortness of breath and hives. Suspect allergic reaction to the COVID-19 vaccine. Patient had already taken 50 mg of Benadryl. She was given Solu-Medrol and EpiPen. She reported feeling better with improvement in the pruritus. She reports that she has had rebound reaction requiring EpiPen at 24 hours. Given the distance that she lives from adequate medical care and the possibility for recurrent severe reactions, the patient will be hospitalized for further observation. 12-23 Female with history of asthma and addison''s had anaphylaxis to covid vaccine. Admitted over night to ensure that she did not rebound. Received IV Dex and this am has had no reoccurrence of hives or shortness of breath. Will discharge home on epipen, hydrocortisone prn, prednisone bid for 5 days. Return to ER or go to PCP for worsening symptoms.


VAERS ID: 907635 (history)  
Form: Version 2.0  
Age: 48.0  
Sex: Female  
Location: Delaware  
Vaccinated:2020-12-23
Onset:2020-12-23
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EH9899 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Swollen tongue, Throat irritation
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Oropharyngeal allergic conditions (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies: Nitrile
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient received covid 19 vaccine. She began to experience itching throat and swollen tongue. She was sent to the Emergency Department. She received IV Benadryl 50 mg, IV famotidine 20 mg and 125 mg IV solu-medrol. Around 930, patient stated that symptoms had resolved, except for tongue being slightly swollen. Patient was admitted to the observation unit of the hospital.


VAERS ID: 907649 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Virginia  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Rash, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Allergic reaction to bee sting
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2020502532

Write-up: sent to the emergency room for body rashes and hives.; sent to the emergency room for body rashes and hives.; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar events for 4 patients. This is the 1st of four reports. A patient with unspecified age and gender received BNT162B2 via unspecified route of administration on unspecified date at single dose for COVID-19 immunization. Medical history included allergies to bee stings. Concomitant medications were not reported. On unspecified date, the patient was sent to the emergency room for body rashes and hives, and they were recommending that those with a bee sting allergy hold off until they know more. The outcome of events was unknown. Information on the lot/batch number has been requested.; Sender''s Comments: Linked Report(s) : US-PFIZER INC-2020502533 same reporter/ drug/ events, different patient;US-PFIZER INC-2020502534 same reporter/ drug/ events, different patient;US-PFIZER INC-2020502535 same reporter/ drug/ events, different patient


VAERS ID: 907650 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Virginia  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Rash, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Allergic reaction to bee sting (allergies to bee stings)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2020502533

Write-up: 4 different individuals sent to the emergency room for body rashes and hives.; 4 different individuals sent to the emergency room for body rashes and hives.; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar events for 4 patients. This is a second of four reports. A patient of unspecified age and gender received BNT162B2 (lot/batch number and expiration date not provided), via an unspecified route of administration on an unspecified date at single dose for immunization. Medical history included allergies to bee stings from an unknown date. The patient''s concomitant medications were not reported. The patient was sent to the emergency room for body rashes and hives. They are recommending that those with a bee sting allergy hold off until they know more. The outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender''s Comments: Linked Report(s) : US-PFIZER INC-2020502532 same reporter, event and drug but different patient


VAERS ID: 907651 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Virginia  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Rash, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Allergic reaction to bee sting
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2020502535

Write-up: sent to the emergency room for body rashes and hives.; sent to the emergency room for body rashes and hives.; This is a spontaneous report from a contactable pharmacist. This pharmacist reported same events for 4 patients. This is the 4th of four reports. A patient of unspecified age and gender received BNT162B2 via an unspecified route of administration, on an unspecified date at single dose for immunization. Medical history included allergies to bee stings. It was reported that the patient sent to the emergency room post vaccine for body rashes and hives. There seemed to be a commonality of allergies to bee stings for the 4 different individuals. The pharmacist wondered if there are other reports of this. They are recommending that those with a bee sting allergy hold off until knowing more and wondered if any guidance from Pfizer. Event took place after use of product. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender''s Comments: Linked Report(s) : US-PFIZER INC-2020502532 same reporter, drug, event but different patient


VAERS ID: 907785 (history)  
Form: Version 2.0  
Age: 46.0  
Sex: Female  
Location: Virginia  
Vaccinated:2020-12-22
Onset:2020-12-22
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EH9899 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Asthenia, Dizziness, Fatigue, Myalgia, Nausea, Pyrexia, Urticaria
SMQs:, Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (broad), Acute pancreatitis (broad), Angioedema (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Eosinophilic pneumonia (broad), Vestibular disorders (broad), Hypersensitivity (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Seasonique Birth Control
Current Illness: N/A
Preexisting Conditions: N/A
Allergies: N/A
Diagnostic Lab Data: N/A
CDC Split Type:

Write-up: Upper body hives, Low grade fever 99.6, dizziness, weakness, tiredness, upper body muscle pain, nausea. All lasting 24 hours+.


VAERS ID: 907816 (history)  
Form: Version 2.0  
Age: 43.0  
Sex: Female  
Location: Arizona  
Vaccinated:2020-12-18
Onset:2020-12-18
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Cough, Pyrexia, SARS-CoV-2 test negative, Urticaria
SMQs:, Anaphylactic reaction (narrow), Angioedema (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: I have asthma
Allergies:
Diagnostic Lab Data: COVID19 test on 12/22/2020 results-NEG
CDC Split Type: vsafe

Write-up: I had a cough , hives and a fever of 101


Result pages: prev   12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=21&SYMPTOMS[]=Anaphylactic_reaction_%2810002198%29&SYMPTOMS[]=Anaphylactic_shock_%2810002199%29&SYMPTOMS[]=Anaphylactoid_reaction_%2810002216%29&SYMPTOMS[]=Anaphylactoid_shock_%2810063119%29&SYMPTOMS[]=Swollen_tongue_%2810042727%29&SYMPTOMS[]=Tongue_paralysis_%2810043972%29&SYMPTOMS[]=Tongue_pruritus_%2810070072%29&SYMPTOMS[]=Urticaria_%2810046735%29&SYMPTOMS[]=Urticaria_aquagenic_%2810046739%29&SYMPTOMS[]=Urticaria_cholinergic_%2810046740%29&SYMPTOMS[]=Urticaria_chronic_%2810052568%29&SYMPTOMS[]=Urticaria_contact_%2810046742%29&SYMPTOMS[]=Urticaria_generalised_%2810052569%29&SYMPTOMS[]=Urticarial_vasculitis_%2810048820%29&SYMPTOMS[]=Urticaria_papular_%2810046750%29&SYMPTOMS[]=Urticaria_pigmentosa_%2810046752%29&SYMPTOMS[]=Urticaria_pressure_%2810052572%29&SYMPTOMS[]=Urticaria_thermal_%2810061399%29&SYMPTOMS[]=Urticaria_vesiculosa_%2810046755%29&VAX=COVID19


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166